• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柠檬酸盐的病理生理学与代谢

Citrate pathophysiology and metabolism.

作者信息

Monchi Mehran

机构信息

Intensive care deparment, Centre Hospitalier de Melun, Melun, F-77000, France.

出版信息

Transfus Apher Sci. 2017 Feb;56(1):28-30. doi: 10.1016/j.transci.2016.12.013. Epub 2016 Dec 30.

DOI:10.1016/j.transci.2016.12.013
PMID:28073690
Abstract

By chelating ionized calcium, citrate allows extracorporeal circuit anticoagulation without a bleeding risk for the patient. Citrate anticoagulation is also associated with a reduced activation of leucocytes and platelets. Citrate clearance by citric acid cycle (Krebs cycle) is not modified by renal failure, but is reduced by about 50% in patients with cirrhosis. Toxic effects of citrate result from a decrease in plasma ionized calcium of the patient. The first side effect is a prolongation of the QT interval. Clinical signs of hypocalcemia and hypotension in humans appear below 0.9mmol/L of plasma ionized calcium.

摘要

通过螯合离子钙,枸橼酸盐可实现体外循环抗凝,且不会给患者带来出血风险。枸橼酸盐抗凝还与白细胞和血小板的活化减少有关。通过柠檬酸循环(克雷布斯循环)进行的枸橼酸盐清除不受肾衰竭影响,但在肝硬化患者中会降低约50%。枸橼酸盐的毒性作用源于患者血浆离子钙的降低。第一个副作用是QT间期延长。人体血浆离子钙低于0.9mmol/L时会出现低钙血症和低血压的临床症状。

相似文献

1
Citrate pathophysiology and metabolism.柠檬酸盐的病理生理学与代谢
Transfus Apher Sci. 2017 Feb;56(1):28-30. doi: 10.1016/j.transci.2016.12.013. Epub 2016 Dec 30.
2
Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation.采用局部枸橼酸抗凝法进行血液透析时粒细胞激活的减少:补体激活及中性粒细胞减少与中性粒细胞脱颗粒的分离
J Am Soc Nephrol. 1996 Feb;7(2):234-41. doi: 10.1681/ASN.V72234.
3
Citrate clearance in children receiving continuous venovenous renal replacement therapy.接受持续静静脉肾脏替代治疗的儿童的枸橼酸盐清除率
Pediatr Nephrol. 2002 Oct;17(10):819-24. doi: 10.1007/s00467-002-0963-6. Epub 2002 Sep 7.
4
Treatment Efficacy and Safety During Plasma Exchange With Citrate Anticoagulation: A Randomized Study of 4 Versus 15% Citrate.枸橼酸盐抗凝血浆置换治疗的疗效与安全性:4%与15%枸橼酸盐的随机对照研究
Artif Organs. 2016 Apr;40(4):368-75. doi: 10.1111/aor.12559. Epub 2015 Sep 14.
5
The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters.离子钙和镁在局部枸橼酸盐抗凝中的作用及其对炎症参数的影响。
Int J Artif Organs. 2017 Mar 6;40(1):15-21. doi: 10.5301/ijao.5000558. Epub 2017 Feb 13.
6
A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges.治疗性血浆置换中局部枸橼酸盐抗凝的新处方模式。
BMC Nephrol. 2017 Mar 1;18(1):81. doi: 10.1186/s12882-017-0494-9.
7
Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement.用于连续性肾脏替代治疗(CRRT)且无需补充钙剂的简化枸橼酸盐抗凝法
ASAIO J. 2015 Jul-Aug;61(4):437-42. doi: 10.1097/MAT.0000000000000226.
8
Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation.在采用局部枸橼酸盐抗凝的持续静脉-静脉血液透析过程中总钙与离子钙比值升高。
Crit Care Med. 2001 Apr;29(4):748-52. doi: 10.1097/00003246-200104000-00010.
9
Effects of sodium citrate, citric acid and lactic acid on human blood coagulation.柠檬酸钠、柠檬酸和乳酸对人体血液凝固的影响。
Perfusion. 2018 Oct;33(7):577-583. doi: 10.1177/0267659118777441. Epub 2018 May 22.
10
Citrate anticoagulation for single-needle hemodialysis: safety and efficacy.单针血液透析的枸橼酸盐抗凝:安全性与有效性
Ther Apher Dial. 2005 Jun;9(3):237-40. doi: 10.1111/j.1774-9987.2005.00262.x.

引用本文的文献

1
Metabolomic insights into vitreous humor with therapy outcome in type 2 diabetic retinopathy.2型糖尿病视网膜病变玻璃体的代谢组学见解与治疗结果
BMC Ophthalmol. 2025 Aug 15;25(1):460. doi: 10.1186/s12886-025-04283-6.
2
Citrate regional anticoagulation of 500 ml/min of extracorporeal blood flow: an experimental study.体外血流速度为500毫升/分钟时的枸橼酸盐局部抗凝:一项实验研究。
Intensive Care Med Exp. 2025 Jun 24;13(1):64. doi: 10.1186/s40635-025-00771-7.
3
Comparison of regional citrate anticoagulation and nafamostat mesylate anticoagulation during plasma exchange for children at high bleeding risk: a retrospective study.
高出血风险儿童血浆置换期间局部枸橼酸抗凝与甲磺酸萘莫司他抗凝的比较:一项回顾性研究。
Ital J Pediatr. 2025 Apr 12;51(1):114. doi: 10.1186/s13052-025-01954-4.
4
Electromagnetic Iontophoresis: A Novel Nonsurgical Method for the Treatment of Dense Vitreous and Retinal Hemorrhages.电磁离子导入法:一种治疗致密玻璃体及视网膜出血的新型非手术方法。
Case Rep Ophthalmol. 2025 Feb 27;16(1):221-231. doi: 10.1159/000544755. eCollection 2025 Jan-Dec.
5
Strategies to Prevent Hemodialysis Catheter Dysfunction.预防血液透析导管功能障碍的策略。
J Am Soc Nephrol. 2025 May 1;36(5):952-966. doi: 10.1681/ASN.0000000666. Epub 2025 Feb 20.
6
Synthesis and Application of Silver Nanoparticles for Caries Management: A Review.用于龋齿管理的银纳米颗粒的合成与应用:综述
Pharmaceuticals (Basel). 2024 Sep 25;17(10):1264. doi: 10.3390/ph17101264.
7
Ratios of calcium to citrate administration in blood transfusion for traumatic hemorrhage: A retrospective cohort study.创伤性出血输血中钙与柠檬酸盐给药比例:一项回顾性队列研究。
Transfusion. 2024 Nov;64(11):2104-2113. doi: 10.1111/trf.18029. Epub 2024 Oct 1.
8
Citrate-Buffered, Magnesium-Enriched Dialysate on Calcification Propensity in Hemodialysis Patients - The CitMag Study.柠檬酸缓冲、富镁透析液对血液透析患者钙化倾向的影响——CitMag研究
Kidney Int Rep. 2024 Mar 25;9(6):1765-1773. doi: 10.1016/j.ekir.2024.03.023. eCollection 2024 Jun.
9
First In Vivo Applicational Data of Foam-Based Intrathoracic Chemotherapy (FBiTC) in a Swine Model.基于泡沫的胸腔内化疗(FBiTC)在猪模型中的首次体内应用数据。
Pharmaceuticals (Basel). 2023 Dec 27;17(1):45. doi: 10.3390/ph17010045.
10
Drug Distribution and Penetration of Foam-Based Intraperitoneal Chemotherapy (FBIC).基于泡沫的腹腔内化疗(FBIC)的药物分布与渗透
Pharmaceuticals (Basel). 2023 Oct 2;16(10):1393. doi: 10.3390/ph16101393.